INS and exocrine pancreatic insufficiency: Future in-depth evaluations of the impact of surgical treatment approaches for pancreatic malignancies on quality of life should consider advances in both pancreatic surgery (e.g., concomitant islet cell autotransplantation) and management of pancreatic insufficiency (e.g., modern glucose monitors and insulin delivery devices).